It all started with our family dog - Sasha.

In 1998, we were faced with her arthritis diagnosis and the only treatment options available at the time were nonsteroidal anti-inflammatory drugs (NSAIDs). Whilst NSAIDs can be effective in short term alleviation of pain associated with osteoarthritis, they have a range of potential side effects associated with chronic use, which can impact kidney and gastrointestinal function. Given that Sasha was only 11 years old, we were concerned about the long-term use of NSAIDs to manage her arthritis.

We saw the moment as an opportunity to not only support Sasha, but also countless treasured pets with joint health concerns and embarked on a search for a safe natural alternative.

1998 Interpath Global Established 2001 Interpath Launched Sashas™ Blend 2003 Interpath Discovered Epiitalis® 2008 Chondrocyte Cell Proliferation Research 2013 Interpath Launched 4CYTE™ with Equine Granules 2014 4CYTE™ Introduced Canine Granules 2015 4CYTE™ Introduced Epiitalis® Forte Horse 2016 Interpath Launched OSTEO-restore™ for Humans 2019 4CYTE™ Introduced Epiitalis® Forte Dog 2021 4CYTE™ Introduced Epiitalis® Forte Cat 2022 Our Human Clinical Research was Published in the Inflammopharacology Journal 2022 Our CSU DMOAD Research was Published in Frontiers Veterinary Science Journal 2024 Interpath Launched Epijoint® for Humans

Today

We are proud to say that 4CYTE™ with Epiitalis® is the most widely used joint health supplement for animals in Australia and Australasia. We are also exceptionally excited to see our new Human Product Epijoint grow and assist people of all ages.

As leaders in joint health, our dedication to evolving the science of our field is ongoing. We are deeply grateful for the trust our customers place in us as we keep innovating and improving our products to better support you and your animals to lead happier, healthier and more active lives.